Search

Search Constraints

You searched for: Author/Creator Nanus, David M.

Search Results

1. All‐trans retinoic acid (ATRA)‐induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL). (13th January 2020)

2. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Issue 5 (19th December 2017)

3. Clinical features of neuroendocrine prostate cancer. (November 2019)

4. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer. Issue 4 (28th November 2019)

5. Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. Issue 5 (18th November 2013)

6. Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. Issue 5 (18th November 2013)

7. Imaging expression of prostate‐specific membrane antigen and response to PSMA‐targeted β‐emitting radionuclide therapies in metastatic castration‐resistant prostate cancer. Issue 5 (19th January 2021)

8. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma. Issue 1 (31st December 2023)

10. Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer. Issue 15 (23rd April 2019)